XOMA Royalty (XOMA) Invested Capital (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Invested Capital came in at $106.9 million in Q1 2026, up 36.5% year-on-year from $78.3 million in Q1 2025, and up 10.8% quarter-over-quarter from $96.5 million in Q4 2025.

XOMA Royalty (XOMA) Invested Capital (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Invested Capital across 17 years of filings, most recently posting $106.9 million for Q1 2026.

  • Invested Capital for Q1 2026 came in at $106.9 million, up 36.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.9 million (up 36.5% YoY), and the FY2025 annual result was $96.5 million, up 31.61% from the prior year.
  • Invested Capital came in at $106.9 million for Q1 2026 at XOMA Royalty, up from $96.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $139.9 million in Q1 2022 to a low of $68.5 million in Q1 2024.
  • The 5-year median for Invested Capital is $102.3 million (2025), against an average of $100.2 million.
  • Across the five-year window, Invested Capital soared 57.36% in 2022 and sank 40.22% in 2024, its largest moves.
  • XOMA Royalty's Invested Capital stood at $124.0 million in 2022, then slumped by 40.13% to $74.2 million in 2023, then decreased by 1.28% to $73.3 million in 2024, then jumped by 31.61% to $96.5 million in 2025, then rose by 10.8% to $106.9 million in 2026.
  • The last three Invested Capital figures came in at $106.9 million (Q1 2026), $96.5 million (Q4 2025), and $102.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 7.14 Bn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 595,226.00
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 14.38 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 19.36 Bn
9 Abivax 95.45 Bn 95.45 Bn - 502.95 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 106.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 106.89 Mn
Dec 31, 2025 96.47 Mn
Sep 30, 2025 102.28 Mn
Jun 30, 2025 84.11 Mn
Mar 31, 2025 78.31 Mn
Dec 31, 2024 73.30 Mn
Sep 30, 2024 74.62 Mn
Jun 30, 2024 85.69 Mn
Mar 31, 2024 68.47 Mn
Dec 31, 2023 74.25 Mn
Sep 30, 2023 105.96 Mn
Jun 30, 2023 110.12 Mn
Mar 31, 2023 114.53 Mn
Dec 31, 2022 124.01 Mn
Sep 30, 2022 130.33 Mn
Jun 30, 2022 134.96 Mn
Mar 31, 2022 139.92 Mn
Dec 31, 2021 141.88 Mn
Sep 30, 2021 111.58 Mn
Jun 30, 2021 116.58 Mn